×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INAB – in8bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INAB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/13
09:10 am
inab
IN8bio, Inc. (NASDAQ: INAB) had its price target lowered by analysts at HC Wainwright from $12.50 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
IN8bio, Inc. (NASDAQ: INAB) had its price target lowered by analysts at HC Wainwright from $12.50 to $8.00. They now have a "buy" rating on the stock.
11/12
04:30 pm
inab
IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
11/12
04:26 pm
inab
IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Medium
Report
IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
11/12
07:00 am
inab
IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting
High
Report
IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting
11/5
09:00 am
inab
IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting
High
Report
IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting
10/1
08:00 am
inab
IN8bio Announces Pricing of $12.4 Million Private Placement
High
Report
IN8bio Announces Pricing of $12.4 Million Private Placement
9/5
08:18 am
inab
IN8bio cuts staff and pipeline to focus on AML cell therapy [Yahoo! Finance]
High
Report
IN8bio cuts staff and pipeline to focus on AML cell therapy [Yahoo! Finance]
9/4
04:05 pm
inab
IN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid Leukemia [Yahoo! Finance]
High
Report
IN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid Leukemia [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
04:34 pm
inab
Form 10-Q IN8BIO, INC. For: Sep 30
Medium
Report
Form 10-Q IN8BIO, INC. For: Sep 30
11/12
04:31 pm
inab
Form 8-K IN8BIO, INC. For: Nov 12
Medium
Report
Form 8-K IN8BIO, INC. For: Nov 12
10/11
06:14 pm
inab
Form 4 IN8BIO, INC. For: Oct 04 Filed by: Bios Equity Partners, LP
Medium
Report
Form 4 IN8BIO, INC. For: Oct 04 Filed by: Bios Equity Partners, LP
10/11
06:13 pm
inab
Form 4 IN8BIO, INC. For: Oct 04 Filed by: BIOS Capital Management, LP
Medium
Report
Form 4 IN8BIO, INC. For: Oct 04 Filed by: BIOS Capital Management, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: